Adipotide alternatives.
10 compounds compared to Adipotide, ranked by published evidence tier and regulatory status, not by what's marketed hardest.
Adipotide is one of the few compounds here where the search for an alternative should end quickly. It was built as a proof of concept that you could destroy the blood supply feeding white fat rather than act on appetite hormones, and it has only ever been tested in animals. It never completed human clinical trials, has no approval anywhere, and no legitimate human product exists. There is no better-evidenced compound working through the same anti-vascular mechanism, because nothing in that mechanism class made it out of preclinical work. Every alternative you will find below reaches fat mass by a hormonal route instead, which is a different bet entirely.
Adipotide (FTPP, also called prohibitin-targeting peptide-1) is an experimental chimeric peptidomimetic designed to destroy the blood supply of white fat rather than act as a hormone.
- 01AOD-9604D tierResearch / preclinical
Acts through the adipose tissue and lipolysis signalling pathway, like Adipotide. Research / preclinical.
- 02HGH Fragment 176-191F tierResearch / preclinicalhGH frag 176-191 · GH lipolytic fragment
Acts through the adipose tissue and lipolysis signalling pathway, like Adipotide. Research / preclinical.
- 035-Amino-1MQF tierResearch / preclinical
Acts through the adipose tissue and lipolysis signalling pathway, like Adipotide. Research / preclinical.
- 04
- 05
- 06
- 07
- 08
- 09
- 10
An “alternative” here means a compound that shares Adipotide's mechanism pathway or sits in the same category, not a marketing substitute. Each is ordered by PepCue's evidence tier (a weighted 0–100 score across human data, safety, replication and regulatory clarity), then by whether it's actually approved. This is a research reference, not medical or purchasing advice: an alternative sitting higher on evidence does not mean it's right, safe, or legal for any given use. Reviewed June 1, 2026.
PepCue keeps every compound, dose and lab in one private, provider-ready timeline, whichever one you land on.